We would love to hear your thoughts about our site and services, please take our survey here.
Remember, they aren't investors or groups with a legitimate hold or position. They hold a position on something that is yet to exist.
So it's the reverse of how a normal position would work. If it was legitimate they'd have to rebuy lower than the current price. They don't. They only have to rebuy below where the next allotments take place to make on it.
It's not the facility that matters. We know the price of that.
It's my view of what they'd do to the shares that are currently made of thin air. As it's under 2.1p they can print a "buy" at any price between here and that to reconcile the book and pocket the difference between what they "sold" at and the 2.1p.
They only start to lose if they have to print a buy over 2.1p.
I was there during the live feed too and thought the love chat that could be saw by all was disgusting.
There was obviously answers that couldn't be given. It relisted for us at the same rate it closed at before suspension.
What took the price down was how certain parties benefitted from their positions on the way down. That's a lesson learned that of certain people scream about a stock, run. They don't want you to buy. It's complicated and very clever how they do it.
But as for the presentation itself and how things have progressed, I'm happy and optimistic.
I believe we'll do very well here. I don't want to be bought out. I want it to run its course. All parties are well incentivised to make off this too.
Worth a follow if you aren't already
https://twitter.com/CorePath/status/1722395559334420562?s=20
We was talking about this in telegram group last night. Not sure if you are in or not.
It looks unclear. If they have and did so at the top, great.
But the piece makes assumptions and not assertions.
I believe we should be told if the PUT exercise was to sell. Going back to an old debate on what the PUT means for us as opposed to what a PUT traditionally means.
Not just Bio-Techne either.
Corepath, Bosch, Sinopharm to name some others.
We've had Fairjourney do work for us too.
To claim this is a scam or even a lifestyle company when it's clear the wages aren't reflective of that is garbage.
If you want to blame the share price action on anyone, ask, how much of a companies shares can a market maker hold without informing a market.
This end of the market is filled with entities that don't care about you, the investor. The only way to change that is to squeeze them. So when trials are done marker(s) applied for, product launch, this will move fast. They'll have to let go of what stock they are holding.